SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-011104
Filing Date
2018-10-15
Accepted
2018-10-15 06:13:20
Documents
56
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT mbvx_10q.htm 10-Q 848013
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF mbvx_ex311jun30.htm EX-31.1 13031
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF mbvx_ex312jun30.htm EX-31.2 12944
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE mbvx_ex32jun30.htm EX-32 11026
  Complete submission text file 0001654954-18-011104.txt   3004553

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mbvx-20180630.xml EX-101.INS 386289
6 XBRL TAXONOMY EXTENSION SCHEMA mbvx-20180630.xsd EX-101.SCH 32680
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbvx-20180630_cal.xml EX-101.CAL 45259
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbvx-20180630_def.xml EX-101.DEF 97077
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbvx-20180630_lab.xml EX-101.LAB 224064
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbvx-20180630_pre.xml EX-101.PRE 190195
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37861 | Film No.: 181121248
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1